Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression
暂无分享,去创建一个
Qiqin Yin-Goen | George A Cotsonis | Cynthia Cohen | W. Choi | A. Young | G. Birdsong | Q. Yin-Goen | C. Cohen | G. Cotsonis | Melinda M Lewis | Diane Lawson | D. Lawson | Andrew N Young | George G Birdsong | William W L Choi | M. Lewis
[1] Patrick Nicolas,et al. Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. , 2004, Cancer research.
[2] K. Chayama,et al. Expression of VEGF‐C and VEGF‐D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma , 2004, Cancer science.
[3] M. Tonato,et al. Evaluation of the Prognostic Role of Vascular Endothelial Growth Factor and Microvessel Density in Stages I and II Breast Cancer Patients , 2003, Breast Cancer Research and Treatment.
[4] J. Tille,et al. Lymphangiogenesis and tumour metastasis. , 2004, Novartis Foundation symposium.
[5] G. Gasparini,et al. Clinical significance of angiogenic factors in breast cancer , 2004, Breast Cancer Research and Treatment.
[6] S. Tsutsui,et al. Prognostic value of microvessel density in invasive ductal carcinoma of the breast , 2003, Breast cancer.
[7] J. Pammer,et al. CD9 Expression on Lymphatic Vessels in Head and Neck Mucosa , 2003, Modern Pathology.
[8] J. Tille,et al. Lymphangiogenesis and tumor metastasis , 2003, Thrombosis and Haemostasis.
[9] S. Nathanson,et al. Insights into the mechanisms of lymph node metastasis , 2003, Cancer.
[10] A. Harris,et al. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer , 2003, The Journal of pathology.
[11] S. Groshen,et al. Computerized Quantification of Tissue Vascularization Using High-resolution Slide Scanning of Whole Tumor Sections , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[12] P. Argani,et al. Performance Characteristics of a Reverse Transcriptase–Polymerase Chain Reaction Assay for the Detection of Tumor-specific Fusion Transcripts from Archival Tissue , 2003, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[13] Maria Chosia,et al. Angiogenesis as determined by computerised image analysis and the risk of early relapse in women with invasive ductal breast carcinoma. , 2003, Polish journal of pathology : official journal of the Polish Society of Pathologists.
[14] K. Okita,et al. Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymph node metastasis. , 2003, International journal of molecular medicine.
[15] L. Belghiti,et al. Prognostic factors in breast cancer , 2002 .
[16] P. Isaacson,et al. Archival Fixed Histologic and Cytologic Specimens Including Stained and Unstained Materials Are Amenable to RT-PCR , 2002, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[17] J. Nährig,et al. Quantification of CK20 gene and protein expression in colorectal cancer by RT‐PCR and immunohistochemistry reveals inter‐ and intratumour heterogeneity , 2002, The Journal of pathology.
[18] Alexander Marks,et al. A New Monoclonal Antibody, D2-40, for Detection of Lymphatic Invasion in Primary Tumors , 2002, Laboratory Investigation.
[19] K. Alitalo,et al. Metastasis: Lymphangiogenesis and cancer metastasis , 2002, Nature Reviews Cancer.
[20] K. Alitalo,et al. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. , 2002, Investigative ophthalmology & visual science.
[21] M. Pegram,et al. Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/neu protein and vascular endothelial growth factor. , 2002, Seminars in oncology.
[22] G. Jayson,et al. Intra-tumoural microvessel density in human solid tumours , 2002, British Journal of Cancer.
[23] K. Alitalo,et al. VEGF‐C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF‐7 tumors , 2002, International journal of cancer.
[24] Alexander Marks,et al. Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas , 2002, Modern Pathology.
[25] P. Hewett,et al. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. , 2002, Cancer research.
[26] G. Vrensen,et al. VEGFR‐3 in adult angiogenesis , 2001, The Journal of pathology.
[27] K. Chayama,et al. Clinicopathological significance of vascular endothelial growth factor (VEGF)‐C in human esophageal squamous cell carcinomas , 2001, International journal of cancer.
[28] S. Breiteneder-Geleff,et al. Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. , 2001, Anticancer research.
[29] H. Höfler,et al. Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. , 2001, The American journal of pathology.
[30] Thomas Hawighorst,et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis , 2001, Nature Medicine.
[31] Steven A. Stacker,et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics , 2001, Nature Medicine.
[32] Y. Nodasaka,et al. Desmoplakin as a specific marker of lymphatic vessels. , 2001, Microvascular research.
[33] Y. Tokeshi,et al. The Relationship Between Microvessel Density, the Expression of Vascular Endothelial Growth Factor (VEGF), and the Extension of Nasopharyngeal Carcinoma , 2000, The Laryngoscope.
[34] S. Edge,et al. Prognostic factors in breast cancer , 2005 .
[35] S. Hirohashi,et al. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[36] A. Folpe,et al. Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3): A Marker of Vascular Tumors with Presumed Lymphatic Differentiation, Including Kaposi's Sarcoma, Kaposiform and Dabska-Type Hemangioendotheliomas, and a Subset of Angiosarcomas , 2000, Modern Pathology.
[37] K. Alitalo,et al. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors , 1999, Cancer.
[38] G. Oliver,et al. Prox1 Function Is Required for the Development of the Murine Lymphatic System , 1999, Cell.
[39] I. Ellis,et al. Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.
[40] J. Primrose,et al. Optimisation of DNA and RNA extraction from archival formalin-fixed tissue. , 1999, Nucleic acids research.
[41] E. Tschachler,et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. , 1999, The American journal of pathology.
[42] M. Mildner,et al. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[43] K. Alitalo,et al. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. , 1998, The American journal of pathology.
[44] K Vajda,et al. [Prognostic factors in breast cancer]. , 1998, Orvosi hetilap.
[45] E. Tschachler,et al. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. , 1998, Cancer research.
[46] J. Folkman,et al. Angiogenesis and angiogenesis inhibition: an overview. , 1997, EXS.
[47] H. Heinzl,et al. Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma: a comparison of computer-assisted image analysis with established counting methods. , 1996, American journal of clinical pathology.
[48] S. Fox,et al. Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. , 1995, Journal of the National Cancer Institute.
[49] A. Harris,et al. Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis , 1995, The Journal of pathology.
[50] Claudio Eccher,et al. Microvessel density quantification in breast carcinomas. Assessment by light microscopy vs. a computer-aided image analysis system , 1995 .
[51] K. Chew,et al. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. , 1995, Journal of the National Cancer Institute.
[52] A. Norton,et al. Brief, high‐temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues , 1994, The Journal of pathology.
[53] A. Harris,et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer , 1992, The Lancet.
[54] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[55] L. Sobin,et al. Histological Typing of Breast Tumors 1 , 1982 .
[56] R. W. Scarff,et al. Histological typing of breast tumors. , 1982, Tumori.